tiprankstipranks
YS Biopharma (YS)
NASDAQ:YS
US Market

YS Biopharma (YS) Financial Statements

62 Followers

YS Biopharma Financial Overview

YS Biopharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; YS Biopharma is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT--$ -410.67K$ -233.70K$ -302.31K
EBITDA--$ -410.67K$ -233.70K$ -302.31K
Net Income Common Stockholders--$ 1.72M$ 7.13M$ 3.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 53.90M$ 226.77M$ 615.94K$ 720.22K$ 885.20K
Total Assets$ 250.27M$ 1.55B$ 200.93M$ 200.81M$ 201.03M
Total Debt$ 72.56M$ 461.56M$ 0.00$ 0.00$ 0.00
Net Debt$ 18.66M$ 234.80M$ -615.94K$ -720.22K$ -885.20K
Total Liabilities$ 144.26M$ 2.50B$ 11.40M$ 13.00M$ 20.35M
Stockholders Equity$ 728.45M$ -950.69M$ 189.53M$ 187.81M$ 180.68M
Cash Flow-
Free Cash Flow--$ -104.28K$ -164.98K$ -189.94K
Operating Cash Flow--$ -104.28K$ -164.98K$ -189.94K
Investing Cash Flow----$ 0.00
Financing Cash Flow----$ 0.00
Currency in USD

YS Biopharma Earnings and Revenue History

YS Biopharma Debt to Assets

YS Biopharma Cash Flow

YS Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis